Sentences with phrase «pharmaceutical partners in»
«A number of our assays and associated bioinformatics software are currently being used by leading cancer centers and pharmaceutical partners in support of optimizing treatments for patients, and to stratify, enroll, and track MRD in patients in international phase II and phase III clinical studies.
https://www.invivoscribe.com/ Not exact matches
Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.
«At some point this has to end,» John Rountree, partner at Novasecta Limited, says of consolidation in the pharmaceuticals sector.
The Belgian group specialises in the research of novel drugs based on nano - bodies found in the immune systems of llamas and alpacas, for which it partners with several of the world's largest pharmaceutical companies.
The decision, which Gilead will appeal, could force the company to pay Merck and its partner Ionis Pharmaceuticals billions in royalties for U.S. sales of Gilead's hep C mega-blockbusters Sovaldi and Harvoni.
Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California; Editor - in - Chief, Medscape Disclosure: Eric J. Topol, MD, has disclosed the following relevant financial relationships: Serve [d] as a director, officer, partner, employee, advisor, consultant, or trustee for: AltheaDX; Biological Dynamics; Cypher Genomics (Co-founder); Dexcom; Genapsys; Gilead Sciences, Inc.; Portola Pharmaceuticals; Quest Diagnostics; Sotera Wireless; Volcano Received research grant from: National Institutes of Health; Qualcomm Foundation
Epocrates (NASDAQ: EPOC; acquired by Athenahealth in 2013), INC Research (acquired by Avista Capital Partners in 2010), Inspire Pharmaceuticals (IPO 2000, ISPH), IntraLase (IPO 2004, ILSE), LenSx Lasers (acquired by Alcon in 2010), Spinal Dynamics (acquired by Medtronic in 2002), Spiration (acquired by Olympus Medical Systems in 2010)
Research Triangle Park, NC — August 18, 2015 — Phoundry Pharmaceuticals, Inc., an RTP, North Carolina — based company focusing on the discovery of peptide therapeutics, announced today that it has successfully completed its first seed financing, putting it in position to advance its discovery and partnering plans.
Cohodes, the former managing general partner at Copper River Management and current chicken farmer at Alder Lane Farm in California, revisited the cases for why he's short Valeant Pharmaceuticals Inc., The Intertain Group Ltd., Concordia International Corp., and Home Capital Group Inc..
Douglas Loe, healthcare equity analyst with Echelon Wealth Partners, brings more than a decade of experience to financial analysis in the global drug development, medical technology, healthcare services and specialty pharmaceutical sectors.
He brings extensive operating knowledge to Norwest Venture Partners, where he focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology - enabled healthcare services, and specialty pharmaceuticals.
Carlyle bought prescription and over the counter drug maker iNova Pharmaceuticals for $ 930 million last June, in conjunction with Australian buyout firm Pacific Equity Partners.
However, big pharmaceutical companies also have males in their sights, arguing that they too must be vaccinated to prevent the spread of HPV to their sexual partners.
EHS is the principal agency for the advertising, sponsorship, email, and mobile opportunities of more than 75 of the leading healthcare professional societies, associations, and media companies; consumer health sites; and other quality digital partners in the pharmaceutical / healthcare vertical.
Right now Collins, of Clarence, is under a cloud of ethical controversies including his sponsorship for a federal judgeship of John L. Sinatra Jr., the brother of a business partner and his sponsorship of legislation benefiting an Australian pharmaceutical company in which he was a leading stockholder.
This work was inspired by previous cross-coupling chemistry developed in the Baran lab, and catalyzed by discussions with pharmaceutical industry partners who view this as an area of major unmet need.
The results of the Phase II trial now have to be verified in a (multi-centre) clinical Phase III trial — as soon as this trial has been successfully completed and a partner has been found from the pharmaceutical industry, this immunotherapy could be available in a few years for treating apple allergy.
The government of Japan partnered with the United Nations Development Program, the Bill & Melinda Gates Foundation and several Japanese pharmaceutical companies in April to announce that it was forming a new fund to attack neglected diseases and illnesses most impacting the poor.
Two hospitals in Africa also participate in the project, as well as partners from the pharmaceuticals industry.
The new trial — estimated to cost at least $ 100 million overall, with most of the remaining funds provided by partners in the pharmaceutical industry — will be part of the Alzheimer's Prevention Initiative, a large consortium of researchers attempting to identify biomarkers and treatments that can slow or stop the disease.
Given the role of Msi in promoting aggressive disease, the investigators partnered with Robert MacLeod PhD, vice-president of oncology drug discovery at Ionis Pharmaceuticals, to develop next - generation antisense oligonucleotide (ASO) inhibitors against Msi.
«This is the first instance I am aware of where an academic drug discovery group moved a molecule designed to hopefully treat a chronic brain disorder all the way from early discovery to human trials without there being, at some point along the way, a pharmaceutical partner,» said P. Jeffrey Conn, Ph.D., Lee E. Limbird Professor of Pharmacology in the Vanderbilt University School of Medicine and director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD).
The company is looking ahead to Phase II trials and seeking an appropriate partner in the pharmaceutical industry.
The University of Leicester has secured funding from the Medical Research Council (MRC) Proximity to Discovery scheme to support engagement between academic scientists and industry partners to drive biomedical research into «real world» advances in health care, bio-medical and pharmaceutical sectors.
PHILADELPHIA --(April 19, 2018)-- The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and effective.
She is CEO of PsychoGenics Inc., a profitable preclinical CNS service company, CEO of PGI Drug Discovery LLC, a company engaged in psychiatric drug discovery with three partnered Phase II clinical programs and Adjunct Associate Professor of Neuroscience at Mount Sinai School of Medicine, Dr. Leahy has more than 25 years of experience in drug discovery, clinical develop and business development for pharmaceutical and biotechnology companies, including extensive knowledge of technology assessment, licensing, mergers and acquisitions, and strategic planning.
Approximately 500 scientific and engineering team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries.
«A number of these assays and associated bioinformatics software have been validated for use in Invivoscribe's own «LabPMM» clinical laboratories, and they are currently being used by leading cancer treatment centers and pharmaceutical partners, both to optimize treatments for patients, and to stratify, enroll, and track residual disease in patients in international phase II and phase III clinical studies.
The headline was: «Ionis pharmaceuticals licenses IONIS - HTTRx to partner following SUCCESSFUL Phase 1 / 2a Study in patients with Huntington's Disease».
This research focus should also make SciLifeLab an attractive partner for the pharmaceutical industry both in Sweden and globally.
More than 550 scientific and engineering team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental and energy industries.
Ultimately, two of the identified genes led to compounds being studied in drug development projects with pharmaceutical partners.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.
In a separate effort, Partners HealthCare, founded by Brigham and Women's Hospital and MGH, launched Partners Innovation in 2008 to improve the bridge between basic and translational research groups and businesses, thereby accelerating laboratory discoveries and making them more accessible to pharmaceutical companies, device manufacturers and venture capitalistIn a separate effort, Partners HealthCare, founded by Brigham and Women's Hospital and MGH, launched Partners Innovation in 2008 to improve the bridge between basic and translational research groups and businesses, thereby accelerating laboratory discoveries and making them more accessible to pharmaceutical companies, device manufacturers and venture capitalistin 2008 to improve the bridge between basic and translational research groups and businesses, thereby accelerating laboratory discoveries and making them more accessible to pharmaceutical companies, device manufacturers and venture capitalists.
Quanterix has a strategic focus in neurology and neurodegeneration and is working with a rapidly growing network of academic researchers and pharmaceutical and biotech partners to drive advancements in head health research.
MarkMonitor currently partners with well - known tech, fashion, pharmaceutical, automotive, entertainment, and dating companies, and implements top - notch security tools that increase consumer confidence in the brand.
We engage in the design, manufacture and consolidated supply of pharmaceutical packaging, partnering with licence holders and CMOs.
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) 4 Comments
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Leave a Comment
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA), tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) on March 12, 2009 4 Comments»
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA), tagged Activist investment, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) on April 30, 2009 5 Comments»
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA), tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) on April 8, 2009 Leave a Comment»
The Ophthalmology Service partners with various pharmaceutical, medical device, and other research organizations, such as Duke and the University of North Carolina, in the development of advanced treatment techniques.
In order to make sure these talented canine individuals retain their eyesight and do not suffer from vision problems, the American College of Veterinary Ophthalmologists (ACVO) has partnered with Merial Pharmaceuticals to offer free eye examinations for all certified service dogs during the month of May.
For example, the company partners with Mission Rabies in its work to eradicate rabies worldwide by providing approximately $ 60,000 in health care supplies — including pharmaceuticals, syringes, and other veterinary products — to support the organization's canine vaccination efforts in Malawi.
During the ensuing years, Dr. Garner also set up offices in England just north of London in a town called Milton Keynes where he partnered with Europe's largest pharmaceutical company, Intervet, to bring VetPlan (Called Safari Knowledge Systems) to the United Kingdom.
We engage in the design, manufacture and consolidated supply of pharmaceutical packaging, partnering with licence holders and CMOs.
We engage in the design, manufacture and consolidated supply of pharmaceutical packaging, partnering with licence holders and CMOs.
Mr. Damon's commitment to raise $ 1 million through that group and the OneXOne Foundation in the next year was one of a bundle of pledges aimed at water and sanitation from individuals, charities and companies totalling about $ 400 million (including a $ 200 million pledge by Napo Pharmaceuticals to «complete the clinical development of crofelemer, a drug that has potential to treat pediatric diarrhea, and provide it at cost to partner organizations for distribution in the areas with the highest mortality and morbidity associated with diarrheal diseases.»)
Before IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies.